The American Pharmaceutical Security Act aims to strengthen the U.S. market for essential pharmaceutical components by requiring a report from the Centers for Medicare & Medicaid Services (CMS). The main goal is to reduce reliance on foreign suppliers, particularly those considered adversarial, for active pharmaceutical ingredients and key starting materials. The legislation mandates that within one year of its enactment, the CMS Administrator must provide Congress with a report detailing findings and policy suggestions.